Binge Eating Disorder |
BED |
Clinical Trial: Effectiveness of Binge Eating Disorder Treatments
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the long-term effectiveness of three Binge Eating Disorder (BED) treatments.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Eating Disorders | Behavior: Interpersonal Therapy Behavior: Behavioral Weight Loss Treatment Behavior: Guided Self Help | Phase IV |
MedlinePlus related topics: Eating Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Effectiveness of Psychological Treatments for BED
Expected Total Enrollment: 210
Study start: April 2002; Expected completion: March 2005
BED is a serious condition that is associated with psychiatric comorbidity, psychosocial impairment, and obesity. Interpersonal psychotherapy (IPT), behavioral weight loss (BWL) interventions, and guided self help (GSH) treatments for BED have been evaluated, but the safest and most effective treatment has not yet been identified. This study will determine which of these three treatments is most effective in treating BED.
Participants are stratified by negative affect subtype and are randomly assigned for 6 months to one of three treatment groups: IPT, BWL, or GSH. IPT focuses on current interpersonal problems which are hypothesized to increase negative affect and lead to binge eating. BWL interventions involve the adoption of weight loss inducing behaviors. GSH is a shortened version of cognitive behavioral therapy that focuses directly on eating behavior. IPT and BWL patients have 20 treatment sessions; those receiving GSH have 10 sessions. Assessments are made pre-treatment, post-treatment, and at 6, 12, 18, and 24 months after treatment is complete.
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- DSM-IV criteria for Binge Eating Disorder
- Body Mass Index (BMI) between 27 and 45
Location and Contact Information
California
W. Stewart Agras, Stanford, California, 94305, United States; Recruiting
Stewart Agras, MD, Principal Investigator
Missouri
Washington University School of Medicine, St. Louis, Missouri, United States; Recruiting
Denise E. Wilfley, PhD, Principal Investigator
More Information
Record last reviewed: August 2004
Last Updated: October 13, 2004
Record first received: May 12, 2003
ClinicalTrials.gov Identifier: NCT00060762
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Anorexia nervosa (MayoClinic)
- Binge Eating Disorder (Kids Health)

Not Signed In -

